drugset / Trial / NCT02265367

Novel Medication as a Potential Smoking Cessation Aid

NCT02265367

Completed 56 enrolled University of Minnesota
RandomizedCrossoverTriple-blindOther

Summary

The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.

Timeline

Start
2015-01
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Levomilnacipran Small molecule

Indications